中信證券(06030.HK)H股供股獲超購約248.21%
格隆匯3月2日丨中信證券(06030.HK)公佈,承銷協議項下的所有先決條件均已達成,且H股供股已於2022年2月24日下午五時正成為無條件。於2022年2月23日下午四時正,即接納H股供股股份及付款以及申請認購額外H股供股股份及付款的最後期限,公司合共接獲41份有效接納及申請(涉及合共1,189,995,484股H股供股股份)。
有效接納及申請合共相當於H股供股項下可供認購的H股供股股份總數341,749,155股的約348.21%。根據上述認購結果,H股供股中有848,246,329股H股供股股份獲超額認購,相當於H股供股項下可供認購的H股供股股份總數約248.21%。
香港聯交所已批准H股供股股份的上市及買賣。繳足股款的H股供股股份預期將自2022年3月4日上午九時正開始於香港聯交所買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.